| Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster (NCT05463354) | WestVac Biopharma Co., Ltd. | 2022-07-11 |
| Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults (NCT05463068) | Novavax | 2022-07-11 |
| Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients. (NCT06223932) | Serap Yavuz | 2022-07-07 |
| A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years (NCT05345873) | Sinocelltech Ltd. | 2022-07-01 |
| rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19 (NCT05485584) | Sichuan Huiyang Life Science and Technology Corporation | 2022-07-01 |
| Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally. (NCT05385991) | ACM Biolabs | 2022-07-01 |
| Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19 (NCT05220241) | Fondation Ophtalmologique Adolphe de Rothschild | 2022-07-01 |
| A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More (NCT05439824) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-06-28 |
| Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention (NCT05844202) | Alvea Holdings, LLC | 2022-06-27 |
| Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19 (NCT05049213) | National Taiwan University Hospital | 2022-06-24 |
| A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins (NCT05367843) | Speransa Therapeutics | 2022-06-20 |
| Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project (NCT04907890) | Neuromed IRCCS | 2022-06-14 |
| Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects (NCT05518695) | Bio-Thera Solutions | 2022-06-09 |
| Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2 (NCT05438498) | MediMergent, LLC | 2022-06-03 |
| Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults. (NCT05490108) | Shanghai Zerun Biotechnology Co.,Ltd | 2022-06-02 |
| Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine (NCT05409261) | ANRS, Emerging Infectious Diseases | 2022-06-02 |
| Evaluation of the Relationship of Vitamin D and Vitamin D Binding Protein With Disease Severity in Pediatric Sars-CoV2 (NCT05598957) | Marmara University | 2022-06-01 |
| Impact of the COVID-19 Pandemic on the Health Status of People Aged 75 and Over and Their Caregivers (NCT05249868) | Gerencia de Atención Primaria, Madrid | 2022-06-01 |
| Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome (NCT05421208) | Vanderbilt University Medical Center | 2022-06-01 |
| Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19 (NCT05384561) | Université du Québec à Trois-Rivières | 2022-05-31 |
| A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines (NCT05323461) | Sinocelltech Ltd. | 2022-05-30 |
| Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (NCT05372588) | Novavax | 2022-05-25 |
| COVID-19 Observational Research Collaboratory (NCT05394025) | VA Office of Research and Development | 2022-05-18 |
| Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda (NCT07408297) | Victoria Biomedical Research Institute | 2022-05-18 |
| Inhibition of Bradykinin in COVID-19 Infection With Icatibant (NCT05407597) | Belfast Health and Social Care Trust | 2022-05-16 |
| A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults. (NCT05303402) | Hipra Scientific, S.L.U | 2022-05-12 |
| VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection (NCT05364242) | Valneva Austria GmbH | 2022-05-09 |
| Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation (NCT05364268) | AudibleHealth AI, Inc. | 2022-05-04 |
| The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals (NCT05552950) | Chemi-Pharm AS | 2022-05-01 |
| To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19. (NCT05351437) | Memo Therapeutics AG | 2022-04-26 |
| Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea (NCT05409300) | ANRS, Emerging Infectious Diseases | 2022-04-25 |
| Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail (NCT05358873) | Chulalongkorn University | 2022-04-20 |
| Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients (NCT05334654) | University Magna Graecia | 2022-04-20 |
| Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age (NCT05310084) | BioNTech SE | 2022-04-20 |
| Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19 (NCT05256589) | Sona Nanotech Inc | 2022-04-19 |
| Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos (NCT05697068) | San Diego State University | 2022-04-11 |
| Humoral and Cellular Immunity in First-cycle SARS-CoV-2 Vaccinated COVID-19 Patients (NCT05338736) | University Magna Graecia | 2022-04-01 |
| A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years (NCT05308602) | Sinocelltech Ltd. | 2022-04-01 |
| A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine (NCT05239806) | Sinocelltech Ltd. | 2022-04-01 |
| Tobacco Use and the Risk of COVID-19 and Adverse Outcomes (NCT05321433) | Karolinska Institutet | 2022-04-01 |
| A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19 (NCT05263908) | Pfizer | 2022-03-31 |
| NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19 (NCT05292274) | NYU Langone Health | 2022-03-30 |
| A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine (NCT05238441) | Sinocelltech Ltd. | 2022-03-20 |
| A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine (NCT05238454) | Sinocelltech Ltd. | 2022-03-20 |
| Impact of the Postponement of Surgery on Postoperative Morbidity After Sars-cov-2 Infection (NCT05336110) | Société Française d'Anesthésie et de Réanimation | 2022-03-14 |
| COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients (NCT05587868) | Indonesia University | 2022-03-11 |
| Prevalence of Knowledge, Attitudes and Perception of Covid Vaccine in Iraq. A Cross Sectional Study (NCT05256602) | AlFayhaa General Hospital | 2022-03-07 |
| Chronic Mouth Breathing and SARS-CoV-2 Positivity in the Pediatric Population (NCT07063134) | Dokuz Eylul University | 2022-03-02 |
| Understanding the Long-term Impact of COVID on Children and Families (NCT05172011) | NYU Langone Health | 2022-03-01 |
| A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19) (NCT05112848) | Novavax | 2022-02-28 |
| Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique (NCT05362682) | International Vaccine Institute | 2022-02-24 |
| This Trial is a Clinical Performance Validation Study That Will Evaluate the Clinical Agreement of the Sky Medical™ Rapid Antigen Test Comparing the Antigen Rapid Test to RT-PCR (NCT05491993) | Sky Medical Supplies & Equipments, LLC | 2022-02-22 |
| Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent (NCT05230940) | Health Institutes of Turkey | 2022-02-18 |
| A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals (NCT05210101) | Sophia Koo, M.D. | 2022-02-07 |
| Hypothesizing the Genesis of Infectious Diseases and Epidemics Through an Integrated Systems Biology Approach (NCT05557539) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2022-02-07 |
| A Study of EDP-235 in Healthy Subjects (NCT05246878) | Enanta Pharmaceuticals, Inc | 2022-01-28 |
| AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation (NCT05220306) | AIDAR Health, Inc. | 2022-01-27 |
| I VACCIN Hospitalization of COVID-19 Patients (NCT05244343) | Eshmoun Clinical Research Center | 2022-01-25 |
| Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19 (NCT05210179) | Health Institutes of Turkey | 2022-01-24 |
| Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2) (NCT05178173) | University of North Carolina, Chapel Hill | 2022-01-20 |
| Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load. (NCT05290987) | P & B Group | 2022-01-14 |
| Evaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POC (NCT05514691) | bioLytical Laboratories | 2022-01-13 |
| A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2 (NCT05113862) | Gylden Pharma Ltd | 2022-01-10 |
| Nosocomial COVID-19 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021 (NCT05567874) | Centre Hospitalier Régional Metz-Thionville | 2022-01-03 |
| Physical and Cognitive Impairments in People Suffering From Long COVID (NCT05216536) | Laval University | 2022-01-02 |
| Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19 (NCT05160779) | Leonardo Paroche de Matos | 2022-01-01 |
| Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness (NCT05172063) | Children's Cancer Hospital Egypt 57357 | 2022-01-01 |
| LEAP-CT for Treatment of COVID-19 Patients (Master Protocol) (NCT05077332) | Leidos Life Sciences | 2021-12-29 |
| An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission (NCT05171829) | Hospital Clinic of Barcelona | 2021-12-27 |
| The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine. (NCT05043311) | Sinocelltech Ltd. | 2021-12-22 |
| The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine. (NCT05043285) | Sinocelltech Ltd. | 2021-12-22 |
| Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine (NCT05109559) | Mahidol University | 2021-12-20 |
| Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above (NCT05163652) | Chinese Academy of Medical Sciences | 2021-12-18 |
| ImmuneSense™ COVID-19 Cross-Reactivity Study (NCT05112874) | Adaptive Biotechnologies | 2021-12-15 |
| Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2) (NCT05244330) | First Affiliated Hospital Xi'an Jiaotong University | 2021-12-15 |
| CovidSurg-3: Outcomes of Surgery in COVID-19 Infection (NCT05161299) | University of Birmingham | 2021-12-13 |
| Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study. (NCT05562479) | Novafem | 2021-12-12 |
| A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults (NCT05142306) | Emergent BioSolutions | 2021-12-07 |
| Psychological Well-being and Burnout in Healthcare Workers During the COVID-19 (Coronavirus Disease 2019) Pandemic (NCT05394051) | Northwestern University | 2021-12-01 |
| Transplacental Transmission of COVID-19 (NCT05124574) | Centre Hospitalier Universitaire de Saint Etienne | 2021-12-01 |
| Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern (NCT05168813) | COVID-19 Prevention Network | 2021-12-01 |
| SP16 as a Therapeutic for COVID-19 Induced ARDS (NCT05135624) | Serpin Pharma, LLC | 2021-12-01 |
| Recovering From COVID-19 (NCT05302960) | Imperial College London | 2021-11-30 |
| Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity Evidence (NCT05205746) | Laboratorio Avi-Mex, S.A. de C.V. | 2021-11-23 |
| Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection (NCT05109611) | Sanotize Research and Development corp. | 2021-11-20 |
| A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW) (NCT05036941) | Ascend Performance Materials | 2021-11-13 |
| PERC Health Canada COVID-19 (NCT05040763) | University of Calgary | 2021-11-10 |
| Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. (NCT05148845) | Wits Health Consortium (Pty) Ltd | 2021-11-10 |
| Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19 (NCT05599919) | Sanotize Research and Development corp. | 2021-11-01 |
| Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment (NCT05119738) | Pontificia Universidad Catolica de Chile | 2021-10-27 |
| T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients (NCT05141058) | Children's National Research Institute | 2021-10-19 |
| Safe and Healthy Schools (NCT05105789) | University of Wisconsin, Madison | 2021-10-11 |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects (NCT05017168) | Celltrion | 2021-10-11 |
| A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult Volunteers (NCT05007275) | Imperial College London | 2021-10-10 |
| Phase 3 Booster Vaccination Against COVID-19 (NCT05077176) | Health Institutes of Turkey | 2021-10-08 |
| COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability (NCT05584189) | MP Biomedicals, LLC | 2021-10-07 |
| Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant (NCT05124509) | Pontificia Universidad Catolica de Chile | 2021-10-06 |
| Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19） (NCT05065619) | Medicago | 2021-10-02 |
| COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older (NCT04848467) | Bayer | 2021-10-01 |
| Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection. (NCT05007236) | Rhizen Pharmaceuticals SA | 2021-09-20 |